2 options
The chemistry of gallic acid and its role in health and disease / edited by Jeff C. Murdoch.
- Format:
- Book
- Series:
- Chemistry Research and Applications Series
- Language:
- English
- Subjects (All):
- Antioxidants--Therapeutic use.
- Antioxidants.
- Phenols--Physiological effect.
- Phenols.
- Physical Description:
- 1 online resource (198 pages)
- Edition:
- 1st ed.
- Place of Publication:
- New York, New York : Nova Science Publishers, Incorporated, [2023]
- Summary:
- This book explores the latest developments in gallic acid research and its role in health and disease.
- Contents:
- Intro
- Contents
- Preface
- Chapter 1
- Gallic Acid: From Chemistry to Analysis
- Abstract
- Abbreviations
- Introduction
- Chemistry and Physico-Chemical Properties of Gallic Acid
- Analytical Perspective of Gallic Acid
- Ultraviolet Spectroscopy
- Infrared Spectroscopy (IR)
- Nuclear Magnetic Resonance (NMR)
- Mass Spectrometry (MS)
- Thin Layer Chromatography (TLC)
- High Performance Thin Layer Chromatography (HPTLC)
- High Performance Liquid Chromatography (HPLC)
- Conclusion
- References
- Chapter 2
- A New Perspective on the Efficacy of Gallic Acid in the Treatment of Breast Cancer
- Source and Chemistry of Gallic Acid
- Biological Properties of Gallic Acid
- Bioavailability and Toxicity of Gallic Acid
- Signs and Symptoms of Breast Cancer [41-47]
- Types of Breast Cancer [41-47]
- Therapeutic Role of Gallic Acid
- Chapter 3
- A New Perspective on the Efficacy of Gallic Acid in the Treatment of Lung Cancer
- Lung Cancer
- Gallic Acid
- Chemistry of Gallic Acid
- Different Pathways Involved in Mechanism of Action of Gallic Acid
- The Tendency of Gallic Acid to Prevent DNA Methylation
- Gallic Acid Accelerates EGFR Turnover, Promoting Apoptosis in EGFR-Mutant Non-Small Cell Lung Tumors
- Through the JAK/STAT3 Signaling Pathway, Gallic Acid Possesses Anticancer Action and Amplifies the Anticancer Effects of Cisplatin in Non-Small Cell Lung Cancer A549 Cells
- The Inhibitory Pathways of Tumor Cell PD-L1 Expression in Non-Small-Cell Lung Cancer (NSCLC) Cells by Natural Bioactive Gallic Acid
- Through the Amplification of Glutathione Depletion, MAPK Inhibitors Increase the Mortality of A549 Lung Cancer Cells Caused by Gallic Acid
- Apoptosis Induced in H446 Cell Line Through the ROS-Dependent Mitochondrial Apoptotic Pathway.
- Conclusion
- Chapter 4
- A New Perspective on the Efficacy of Gallic Acid Nanoformulation on Colorectal Cancer Treatment
- Recent Developments, Impact and Challenges in Nanoformulations
- Synthesis Routes of Different Nanoformulations
- Dendrimers Synthesis
- Divergent Growth Method
- Convergent Growth Method
- Magnetite Nanocomposite Formulation of Gallic Acid (Fe3O4-PEG-GA) Against Colon Cancer Cells
- Gallic Acid and Quercetin Chitosan Nanoparticles for Sustained Release in Treating Colorectal Cancer
- Epigallocatechin-3-gallate Nanoparticles
- Polymer Nanoparticles Composed with Gallic Acid-Grafted Chitosan and Bioactive Peptides
- Gallic Acid-Loaded Sodium Alginate Microspheres
- Chitosan and Glyceryl Monooleate Nanostructures Containing Gallic Acid Isolated from Amla Fruit
- Gum Arabic-Stabilized Gallic Acid Nanoparticles
- Chapter 5
- Strategic Approaches of Gallic Acid in Different Disease Conditions
- Anticancer Activity
- Antioxidant Activity
- Antimicrobial Activity
- Anti-Diabetic Activity
- Anti-Obesity Activity
- Anti-Inflammatory Activity
- Cardiovascular Activity
- Chapter 6
- Gallic Acid: A Potential Antidiabetic Agent
- Diabetes Mellitus and Related Complications: Oxidative Stress
- Hyperglycemia and Oxidative Stress
- Insulin Resistance &
- Oxidative Stress
- Gallic Acid: Natural Bioactive Metabolite
- Gallic Acid: Natural Antioxidant
- Gallic Acid in Plants
- Gallic Acid as a Natural Bioactive Metabolite
- Gallic Acid as a Versatile Antioxidant Agent
- Structure Modification of Gallic Acid
- Gallic Acid for Diabetic Therapy
- Diabetic Nephropathy
- Gallic Acid Derivatives and Gallic Acid
- Conclusion.
- References
- Chapter 7
- Gallic Acid: A Potential Anti-Tumor Agent
- Gallic Acid as an Anti-Tumor Agent
- Ovarian Carcinoma
- Colon/Colorectal Cancer
- Lymphoma (Lymphatic Cancer)
- Prostate Cancer
- Breast Cancer
- Oral Cancer
- Esophageal Cancer
- Cervical Cancer
- Leukemia
- Hepatocellular Carcinoma (HCC)
- Melanoma Cells
- Bladder Cancer
- Chapter 8
- In Vitro Anticancer Activity Gallic Acid Nanoparticles on Colon Cancer Cell Colo 205
- Materials and Methods
- Materials
- Plant Material
- Soxhlet Extraction Method
- Phytochemical Screening
- Qualitative Test
- Determination of Total Phenolic Content from Amla Extract
- Techniques of Isolation and Purification of Bioactive Molecules from Amla Extract [14, 15]
- Fractionation of Bioactive Compound by Flash Chromatographic Technique
- Gas Chromatography (GC)
- Structural Clarification of the Bioactive Molecules [16-18]
- UV-Visible Spectroscopy
- FTIR Spectroscopy
- NMR Spectroscopy of the Isolated Compound
- HPLC of Isolated Compounds
- HPTLC of the Isolated Compound
- Determination of Solubility of the Isolated Compound
- Melting Point Determination
- Antioxidant Activity by DPPH Method [19]
- Formulation of Herbal Nanoparticles [21]
- Characterization of Herbal Nanoparticles
- Particle Size and Zeta Potential [22]
- By FTIR Spectroscopy
- Differential Scanning Colorimetry [23]
- In Vitro Release Studies [10]
- In Vitro Anticancer Activity by MTT Assay [24]
- Result and Discussion
- Soxhlet Extraction Method [25]
- Phytochemical Screening [13]
- Qualitative Tests
- Total Phenolic Content [26]
- Techniques of Isolation and Purification of Bioactive Molecules from Amla Fruit.
- Fractionation of Bioactive Compound by Flash Chromatographic Technique
- Separation by Using Column Chromatography
- Gas Chromatography
- Thin Layer Chromatography
- Structural Clarification of the Bioactive Molecules
- FTIR Spectroscopy of the Isolated Compound
- HPLC Analysis of Isolated Compound
- Antioxidant Activity by DPPH Method [30]
- Formulation of Herbal Nanoparticles [33]
- Analysis of Particle Size and Zeta Potential
- FTIR of Herbal Nanoparticles [34]
- Differential Scanning Calorimetry
- In Vitro Release Studies
- In Vitro Anticancer Activity by MTT Assay
- Chapter 9
- Pharmacognosy of Gallic Acid and Its Co-Crystals
- Phytosources of Gallic Acid
- Pharmacological Activities of Gallic Acid
- Structural Aspects of Gallic Acid
- Polymorphs, Solvates/Hydrates, Organic Salts and Co- Crystals
- Gallic Acid Co- Crystals in Pharmaceutical Research
- Biographical Sketches
- Index
- Blank Page.
- Notes:
- Includes index.
- Description based on print version record.
- Other Format:
- Print version: Murdoch, Jeff C. The Chemistry of Gallic Acid and Its Role in Health and Disease
- ISBN:
- 9798886977295
- OCLC:
- 1374425741
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.